Pathways for Navigating ILD and IPF: The Journey to Early Recognition, Diagnosis, and Patient-Centered Disease Management

Released On
October 19, 2018

Expires On
October 18, 2019

Media Type
Internet

Completion Time
Up to 150 minutes

Specialty
Pulmonology, Radiology, Pathology, Primary Care

Topic(s)
Interstitial Lung Disease, Diagnosing IPF, Quality of Life, Communication Strategies

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by National Jewish Health.

Download the companion infographic: Diagnosing IPF Infographic

 

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc..

Credit Available

  • Physicians — up to 2.5 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

Pulmonologists, Radiologists, Pathologists along with Primary Care Physicians, Nurse Practitioners, and Physician Assistants who treat patients with ILD.

Statement of Need/Program Overview

Learners will step through decisions in (3) case simulations to test and reinforce their skills in diagnosis, treatment, and management of ILD/IPF as well as effective patient communication strategies.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe best practices for diagnosing IPF based on the most recent evidence-based guidelines.
  • Differentiate IPF from other interstitial lung diseases through comprehensive assessment, diagnosis, and/or referral to ILD specialty centers.
  • Apply recent clinical data and guidelines to the management and treatment selection of IPF.
  • Determine appropriate communication strategies for addressing quality of life issues in patients with ILD.

Faculty

Michael P. Mohning, MD

Assistant Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health

Zulma X. Yunt, MD

Assistant Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

National Jewish Health designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Faculty

  • Michael Mohning, MD discloses that he is an investigator for Boehringer Ingelheim.
  • Zulma Yunt, MD discloses that she is a speaker for Boehringer Ingelheim.

Planners and Reviewers

  • Michael Sapko, MD, PhD discloses that he is a consultant for Pilsy, MemoryMD, REMD Biotherapeutics and Stemedix.
  • Mandy Comeau has no financial relationships to disclose.
  • Stephanie Corder, ND, RN, CHCP has no financial relationships to disclose.
  • Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.
  • Bethany Hudnutt has no financial relationships to disclose.
  • Laura Muttini has no financial relationships to disclose.
  • Amen Sergew, MD has no financial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete and submit the evaluation and post-test.

Certificates will be available for download at the end of the activity.

Course Viewing Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.